Advertisement

Topics

Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients

2014-08-27 03:41:08 | BioPortfolio

Summary

To compare versus placebo the efficacy and safety of recombinant Bet v1, natural purified Bet v1 and birch pollen licenced extract used for subcutaneous immunotherapy.

Study Design

Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Conditions

Allergy

Intervention

Subcutaneous immunotherapy - Recombinant birch pollen

Location

Pr Gabrielle PAULI
Strasbourg
France
67091

Status

Terminated

Source

Stallergenes

Results (where available)

View Results

Links

Published on BioPortfolio: 2014-08-27T03:41:08-0400

Clinical Trials [614 Associated Clinical Trials listed on BioPortfolio]

Analysis of Immunological Reactions to Foods in Birch Pollen-Allergic Patients

A high number of birch pollen-allergic individuals develop hypersensitivity reactions to certain foods, e.g. apples. This food allergy is due to immunological cross-reactivity. Birch polle...

SUBLIVAC FIX Birch Phase III Short-term Efficacy

The aim of this phase III study is to asses if SUBLIVAC FIX Birch is safe and effective in reducing birch allergy induced symptoms and birch allergy medication usage.

Efficacy and Safety Trial of SLITone(TM) Birch in Subjects With Hayfever

The trial is performed to assess the efficacy and safety of SLIT One birch for treatment of birch pollen induced allergy

Probiotics for Birch Pollen Allergy

Birch pollen allergy is one of the most common forms of respiratory allergy in the Nordic countries. Treatment consists of antihistamine use. Specific probiotic strains have been observed ...

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-Adsorbed Allergoid Preparation of Birch Pollen Allergens

This study is an evaluation of the safety and efficacy of specific immunotherapy with a birch pollen allergoid.

PubMed Articles [2491 Associated PubMed Articles listed on BioPortfolio]

New EAACI definition on pollen season mirrors symptom load for grass and birch pollen-induced allergic rhinitis.

The use of allergen immunotherapy (AIT) for allergic rhinitis and its clinical efficacy in clinical trials depends on the effective determination of pollen allergens exposure time-periods. We evaluate...

Randomised controlled trials define shape of dose-response for Pollinex Quattro Birch allergoid immunotherapy.

The Birch Allergoid, Tyrosine Adsorbate, Monophosphoryl Lipid A (POLLINEX Quattro Plus 1.0 ml Birch 100%) is an effective, well-tolerated short course subcutaneous immunotherapy. We performed two phas...

Birch pollen-related foods can cause late eczematous reactions in patients with atopic dermatitis.

Previous studies have indicated that in patients with atopic dermatitis (AD) and birch pollen allergy related foods are able to cause a late eczematous response. However, the relevance of AD worsening...

Context matters: Th2 polarization resulting from pollen composition and not from protein-intrinsic allergenicity.

In contrast to the pollen context, the major allergen Bet v 1 alone is not responsible for Th2 polarization in allergic sensitization. These findings are highly relevant for birch pollen allergy proph...

Evidence-based dosing of maintenance subcutaneous immunotherapy: a contemporary review of state-of-the-art practice.

Subcutaneous immunotherapy is an effective allergy treatment only if properly dosed. In this article we review the data on the probable effective dose range for subcutaneous immunotherapy and convert ...

Medical and Biotech [MESH] Definitions

A method of treating an ALLERGY by administering ALLERGENS, in liquid formulation or tablets, to the ORAL MUCOSA under the tongue.

A growth from a pollen grain down into the flower style which allows two sperm to pass, one to the ovum within the ovule, and the other to the central cell of the ovule to produce endosperm of SEEDS.

Form of passive immunization where previously sensitized immunologic agents (cells or serum) are transferred to non-immune recipients. When transfer of cells is used as a therapy for the treatment of neoplasms, it is called adoptive immunotherapy (IMMUNOTHERAPY, ADOPTIVE).

The uptake of substances via the SUBCUTANEOUS TISSUE.

Presence of air or gas in the subcutaneous tissues of the body.

More From BioPortfolio on "Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...


Searches Linking to this Trial